Navigation Links
Amylin Sends Letter to Shareholders
Date:5/1/2009

Urges Shareholders to Support the Board's Strategy and Vote the BLUE Proxy Card Today to Elect Amylin's Highly-Qualified Nominees

SAN DIEGO, May 1 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today announced that it is mailing a letter to shareholders in connection with the Company's Annual Meeting of Stockholders on May 27, 2009. Amylin urges all shareholders to vote FOR Amylin's Directors on the BLUE proxy card today and reject the nominees of both Carl Icahn and Eastbourne Capital Management, L.L.C.

The text of the letter from Daniel M. Bradbury, President and Chief Executive Officer, and James N. Wilson, Lead Independent Director, is below:

Dear Fellow Amylin Shareholder:

AMYLIN IS POISED TO REVOLUTIONIZE TREATMENT OF DIABETES AND DELIVER VALUE TO SHAREHOLDERS

Within the next two decades, cases of diabetes are estimated to grow by 55% globally. With over 23 million people with diabetes in the U.S. last year, Amylin is at the center of a rapidly growing market and has the opportunity to deliver transformational therapies to an increasing number of diabetes patients.

If approved by the FDA, Amylin's exenatide once weekly will be the first once-a-week treatment for type 2 diabetes. With no similar drug on the market, we believe it has the potential to transform the treatment of diabetes through its efficacy and convenient once-weekly administration.

To ensure that you benefit from this value opportunity, it is imperative that Amylin has the best possible Board of Directors. Accordingly, your Board strongly recommends that shareholders support Amylin by voting for your Company's highly qualified, dedicated nominees on the BLUE proxy card TODAY - by telephone, Internet, or by signing
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
2. Amylin Pharmaceuticals to Webcast Third Quarter Results
3. Amylin Pharmaceuticals to Webcast Conference Call
4. Amylin Pharmaceuticals to Present at Research & Development Day
5. Xenome Enters Into Joint Research Collaboration to Discover Novel Peptide Therapeutics with Amylin Pharmaceuticals
6. Amylin Pharmaceuticals Reports 2007 Financial Results
7. Amylin Pharmaceuticals Reports First Quarter Financial Results
8. Amylin Pharmaceuticals Diabetes Drug Byetta the Focus of California Lawsuit
9. Lilly and Amylin Set Date and Time for Conference Call
10. Amylin Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference
11. Amylin, Lilly Update on FDA Review of BYETTA(R) (exenatide) Injection Monotherapy Submission
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... New York (PRWEB) April 17, 2015 ... that allege this class of prescription medications increases ... heart attack, stroke or other life-threatening cardiovascular event ... in U.S. District Court, Northern District of Illinois. ... the U.S. Judicial Panel on Multidistrict Litigation (JPML) ...
(Date:4/17/2015)... 17, 2015 Scientists from the ... team of U.S. and Venezuelan researchers, have discovered ... humans among an isolated tribe of Yanomami Amerindians ... diversity in the Yanomami, previously unexposed to antibiotics ... double that of people living in industrialized countries, ...
(Date:4/17/2015)... Calvary Hospital recently announced Timothy P. Barr will be ... May 11. The Fund directs all fundraising efforts in support ... J. Spinelli, who retired several months ago. , “We are ... the important work that the Fund does every year,” said ... expand and bring our signature care to people who need ...
(Date:4/17/2015)... Jersey City, NJ (PRWEB) April 17, 2015 ... is stored in the posterior pituitary and thought to ... strengthening bonding between couples. To further substantiate this, new ... published in the journal, Nature, and reported by Medical ... does have a powerful influence over maternal social behavior. ...
(Date:4/17/2015)... Mario Badescu Botanical Exfoliating ... facial skin with its unique combination of finely ... energizing botanicals. This cushiony gel-based formula sloughs off ... and inhibit penetration of special treatments, serums, and ... Seeds, This uncommon exfoliating ingredient is an ecologically ...
Breaking Medicine News(10 mins):Health News:Testosterone Treatment Lawsuits Increase, as New Report Indicates Over 200 Federal Cases Filed Since March 2Health News:Testosterone Treatment Lawsuits Increase, as New Report Indicates Over 200 Federal Cases Filed Since March 3Health News:Testosterone Treatment Lawsuits Increase, as New Report Indicates Over 200 Federal Cases Filed Since March 4Health News:Mount Sinai Scientists Find Unprecedented Microbial Diversity in Isolated Amazonian Tribe Previously Unexposed to Antibiotics or Processed Foods 2Health News:Mount Sinai Scientists Find Unprecedented Microbial Diversity in Isolated Amazonian Tribe Previously Unexposed to Antibiotics or Processed Foods 3Health News:Timothy P. Barr Appointed Executive Vice President of Calvary Fund 2Health News:Timothy P. Barr Appointed Executive Vice President of Calvary Fund 3Health News:Oxytocin Now Found to Help Diet Doc Patients Whose Weight Has Gotten out of Control Due to Emotional Eating Disorders 2Health News:Oxytocin Now Found to Help Diet Doc Patients Whose Weight Has Gotten out of Control Due to Emotional Eating Disorders 3Health News:Mario Badescu Skin Care Launches Botanical Exfoliating Scrub 2
... SWARTZ CREEK, Mich., Aug. 12 Diplomat Specialty Pharmacy announced today ... 500, Inc.,s annual ranking of the fastest-growing private companies in America. ... nation is an amazing achievement, the additional details are even more resounding," stated ... these: , , , Of the ...
... , , , ... a leading provider of managed care market intelligence, reports that ... contracts that will likely shift thousands of enrollees into new ... Health Plan Analysis , Health Plan of Michigan, Molina Healthcare ...
... use of thiazoles could be possible, research suggests , ... to understanding how a recently approved class of antibiotics ... antibiotics, appear to block a cellular protein called FoxM1, ... according to researchers at the University of Illinois at ...
... WHAT: The Cardiovascular Research Foundation has announced ... TCT (Transcatheter Cardiovascular Therapeutics) 2009, the largest global medical ... TCT 2009 will also feature a new session ... the latest developments in EMR and its relevance to ...
... , THE WOODLANDS, Texas, Aug. 12 Medical oncologist and ... lzang, M.D. has joined the US Oncolo g y ... nsive Cancer Centers of Nevada (CCCN), an affiliate of US Oncolog ... will serve as Chair and Medical Director of the Developmental Therapeutics Committee for US Oncology ...
... , , , , ... -- Atherotech, Inc., developer of the VAP Cholesterol Test, ... continues to grow its cardiodiagnostic business. , , ... heart attack and stroke risk, and the Cystatin C test as ...
Cached Medicine News:Health News:Diplomat Specialty Pharmacy Honored By Inc. Magazine As One Of The Nation's Fastest-Growing Companies 2Health News:New Contract Awards May Shift Thousands of Medicaid Enrollees in Michigan 2Health News:CRF announces late breaking trials to be presented at TCT 2009 in San Francisco 2Health News:CRF announces late breaking trials to be presented at TCT 2009 in San Francisco 3Health News:Nicholas Vogelzang, MD, Joins US Oncology Research Network via Comprehensive Cancer Centers of Nevada 2Health News:Nicholas Vogelzang, MD, Joins US Oncology Research Network via Comprehensive Cancer Centers of Nevada 3Health News:Nicholas Vogelzang, MD, Joins US Oncology Research Network via Comprehensive Cancer Centers of Nevada 4Health News:Atherotech Adds New Cardiometabolic Tests Amid Strong 2009 Growth 2
(Date:4/17/2015)... Nonin Medical, a global leader in noninvasive medical monitoring, ... Steve Bucholz will retire May 1. Company founder ... Chief Executive Officer. In addition, Mr. Isaacson will continue ... transition to David Noel , Chief Financial Officer. ... to Nonin Medical,s growth," Mr. Isaacson said. "Under Steve,s ...
(Date:4/17/2015)... Apr. 17, 2015 Research and Markets ... of the "Medical Device Outsourcing - Global ... This report analyzes the worldwide markets ... the following Device Categories: Class I, Class II, ... in the report Include - Radiology, Orthopedic, Neurology, ...
(Date:4/17/2015)... , Apr. 17, 2015 Research and Markets ... the "Medical Equipment Rental and Leasing - Global ... This report analyzes the worldwide markets for Medical ... provides separate comprehensive analytics for the US, ... Rest of World. Annual estimates and forecasts ...
Breaking Medicine Technology:Nonin Medical's Philip Isaacson Expands CEO Role; President and COO Steve Bucholz to Retire May 1 2Medical Device Outsourcing (Radiology, Orthopedic, Neurology, Cardiology, and Others) Market 2015 - Global Strategic Business Report 2Medical Device Outsourcing (Radiology, Orthopedic, Neurology, Cardiology, and Others) Market 2015 - Global Strategic Business Report 3Medical Equipment Rental and Leasing Market 2015-2020 - Global Strategic Business Report - Healthcare Spending Slowdown Bodes Well for Medical Equipment Leasing 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: